BlackRock’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-2,487
Closed -$21K 3201
2013
Q3
$21K Hold
2,487
﹤0.01% 2271
2013
Q2
$10K Buy
+2,487
New +$13.4K ﹤0.01% 2680

BlackRock's ASTX Position: Q4 2013 in Review

BlackRock sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 2,487 shares — an estimated $21K sold.

BlackRock first reported a position in ASTX in Q2 2013 and held it in 2 quarters. The position peaked at $21K in Q3 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

  • BlackRock reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
  • BlackRock sold 2,487 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $21K.
  • BlackRock first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q2 2013 and held it in 2 quarters.
  • BlackRock's ASTEX PHARMACEUTICALS, INC COM position peaked at $21K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on BlackRock's 13F filing for Q4 2013, filed 12 Feb 2014.